Citius Oncology, Inc.

CTOR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A May 15, 2026
424B3 May 6, 2026 PROSPECTUS SUPPLEMENT
8-K May 6, 2026 CURRENT REPORT
424B3 May 5, 2026 PROSPECTUS SUPPLEMENT
8-K Apr 29, 2026 CURRENT REPORT
8-K Apr 28, 2026 CURRENT REPORT
8-K Mar 31, 2026 CURRENT REPORT
8-K Mar 10, 2026 CURRENT REPORT
8-K Mar 4, 2026 CURRENT REPORT
EFFECT Mar 2, 2026
POS AM Feb 20, 2026 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
SCHEDULE 13G/A Feb 17, 2026
8-K Feb 13, 2026 CURRENT REPORT
10-Q Feb 13, 2026 QUARTERLY REPORT
DEF 14C Jan 29, 2026 DEFINITIVE INFORMATION STATEMENT
PRE 14C Jan 20, 2026 PRELIMINARY INFORMATION STATEMENT
EFFECT Jan 12, 2026
CORRESP Jan 9, 2026
UPLOAD Jan 9, 2026
S-3 Jan 5, 2026 REGISTRATION STATEMENT
8-K Dec 23, 2025 CURRENT REPORT
10-K Dec 23, 2025 ANNUAL REPORT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
4/A Dec 22, 2025 OWNERSHIP DOCUMENT
← Newer Page 2 of 11 · 267 filings Older →